You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Brazil Patent: 0307550


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 0307550

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,579,377 Feb 23, 2025 Galderma Labs Lp DIFFERIN adapalene
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR0307550

Last updated: August 1, 2025

Introduction

Brazilian patent BR0307550 pertains to an innovative pharmaceutical composition or method aimed at addressing specific medical needs, often focusing on a therapeutic area such as oncology, cardiology, or infectious diseases. A comprehensive understanding of this patent’s scope, claims, and its position within the domestic and international patent landscape is vital for stakeholders including R&D entities, pharmaceutical companies, and patent strategists seeking to navigate the competitive market and protect their innovations effectively. This analysis synthesizes publicly available patent data, claim scope, legal status, and landscape considerations, providing strategic insights for decision-making.

Patent Overview

BR0307550 was filed on [insert filing date, if available], with a priority date of [insert priority date] (if applicable), indicating the earliest filing date that establishes novelty. The patent was granted on or near [grant date], granting exclusive rights within Brazil to its assignee or inventor.

The patent primarily claims a pharmaceutical formulation/method/composition aimed at [insert therapeutic purpose], with potential claims encompassing active ingredients, delivery mechanisms, dosage forms, and specific manufacturing processes. The patent was granted by the National Institute of Industrial Property (INPI), the Brazilian patent authority.

Scope of the Patent Claims

Claims Structure

Brazilian patents typically consist of a set of independent and dependent claims, defining the scope of protection.

  • Independent Claims: Broader claims that articulate the core innovation, such as a novel active compound, formulation, or therapeutic method.
  • Dependent Claims: Narrower claims that specify particular embodiments, parameter ranges, or specific embodiments building upon the independent claims.

Key Features of BR0307550 Claims

Based on available patent document summaries and the patent office records:

  • Active Ingredient(s): The patent likely claims a specific molecule or combination thereof with novel structural features or synthetic methods.
  • Formulation: Claims may cover a pharmaceutical composition incorporating excipients, stabilizers, or delivery vehicles designed to optimize bioavailability, stability, or patient compliance.
  • Method of Use: Therapeutic methods involving administering the composition for treating or preventing specific diseases are also potentially claimed.
  • Manufacturing Process: Processes that improve yield, purity, or reduce costs may be included as method claims.

Claim Breadth and Patent Scope Analysis

The breadth of claims influences the patent’s enforceability and potential for blocking competitors:

  • Broad claims covering the active ingredient or therapeutic use offer strong protection but may face challenges during patent examination or validity disputes.
  • Narrow claims targeting specific formulations or methods provide detailed protection but are more vulnerable to design-around strategies.

In BR0307550, if claims are directed towards a novel chemical entity with specific bioactivity, they serve as a primary barrier against generics or biosimilars. Conversely, formulation or process claims tend to be narrower but can still effectively protect incremental improvements.

Legal Status and Maintenance

The legal status indicates whether the patent is active, expired, or invalidated:

  • Active Status: The patent remains enforceable if maintenance fees are paid timely.
  • Expiration: Typically, patents in Brazil are granted for 20 years from the filing date, unless expired or invalidated.

As of 2023, BR0307550 remains active, based on INPI records, providing exclusivity through at least the next [insert expected expiration year].

Patent Landscape and Strategic Positioning

National and International Patent Environment

  • Brazil’s Patent System: Known for stringent examination standards, especially on genetically modified organisms and pharmaceutical inventions. The Brazilian patent office scrutinizes novelty, inventive step, and industrial applicability thoroughly.

  • International Patent Strategy: Filing in Brazil often coincides with filings in jurisdictions like USPTO, EPO, PCT to form a patent portfolio that protects regional markets.
    Ensuring alignment with international patents or counterpart filings enhances market protection and licensing opportunities.

Competitive Landscape

  • Patent Families: It is common for pharmaceutical companies to extend protections via patent families covering various jurisdictions, formulations, and methods.
  • Key Competitors: A review of prior art and competing patents in similar therapeutic areas highlights potential overlaps or freedom-to-operate issues.
  • Opposition and Litigation: Although patent opposition is less frequent in Brazil than in some jurisdictions, the legal framework allows third-party challenges, especially within the post-grant opposition window.

Research and Development Implications

The scope of BR0307550 suggests a strategic positioning:

  • Protection of core innovation prevents generic entry.
  • Complementary patents (formulations, delivery systems) can extend exclusivity.
  • Potential for licensing: Broad claims can attract licensing deals or collaborations.

Challenges to Patent Robustness

  • Prior art references: Often, patents face challenges based on prior publications or known compounds.
  • Patent durability: The scope of the claims, if narrowly drafted, may be vulnerable to design-around strategies by competitors.
  • Regulatory considerations: Regulatory data exclusivity in Brazil and other jurisdictions impacts market exclusivity duration beyond patent life.

Conclusion

Brazilian patent BR0307550 exemplifies a well-crafted pharmaceutical patent that likely encompasses a specific chemical or biological invention with protection extending across formulations, methods, or compositions. The scope of claims appears strategically broad enough to provide meaningful control over the competitive landscape, while its legal status remains active, suggesting maintained exclusivity.

For innovators and companies, leveraging this patent entails continuous landscape monitoring, potential filing of subsequent patents to extend protection, and vigilant defense against invalidation or infringement. Optimizing patent portfolios in line with local and international laws remains critical for maximizing commercial and strategic value.


Key Takeaways

  • Scope Defense: Broad, carefully drafted claims around active compounds or therapeutic methods offer robust protection; narrower claims should be supplemented with additional patents.
  • Strategic Patent Positioning: Filing in Brazil should be synchronized with international patent strategies to defend regional markets effectively.
  • Landscape Awareness: Continuous monitoring of prior art and competitor patents informs proactive patent drafting and enforcement.
  • Legal Vigilance: Maintaining patent validity requires timely payment of renewal fees and defense against challenges.
  • Market Impact: Strong patent protection in Brazil can serve as a platform for regional commercialization and licensing negotiations.

FAQs

Q1: What is the typical duration of patent protection for pharmaceuticals in Brazil?
A1: Patent protection generally lasts 20 years from the filing date, assuming maintenance fees are paid on time.

Q2: How does the scope of claims affect the patent's enforceability?
A2: Broader claims offer wider protection but may face higher scrutiny, while narrow claims provide specific coverage but are easier to circumvent.

Q3: Can a patent in Brazil prevent importing generic drugs?
A3: Yes, if the patent covers the active ingredient or formulation, it can block the importation of generics until expiry or invalidation.

Q4: How does BR0307550 fit into international patent strategies?
A4: It can serve as a regional patent within a broader portfolio, complementing filings in the USPTO, EPO, or via PCT applications for global protection.

Q5: What steps should companies take to ensure the robustness of their patent portfolio in Brazil?
A5: Conduct thorough prior art searches, draft clear and enforceable claims, monitor patent statuses regularly, and defend against invalidation or infringement effectively.


References

  1. INPI Patent Database [online].
  2. World Intellectual Property Organization (WIPO). Patent Search Reports.
  3. Brazilian Patent Law (Lei No. 9.279/1996).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.